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INTRODUCTION
In recent years, there have been considerable efforts to search
for naturally ocurring substances that can inhibit, reverse, or
retard the multi-stage carcinogenesis. A wide array of sub-
stances present in the medicinal herbs or dietary plants have
been screened for their ability to prevent carcinogenesis. A
large number of medicinal or dietary plants have been shown
to exhibit substantial inhibitory effects on experimentally-
induced carcinogenesis, and in many cases their chemopre-
ventive activities are associated with antioxidative and/or anti-
inflammatory properties some of their ingredients retain
(reviewed in 1 and references therein).
The roots or rhizome of many kinds of Panax plants (such
as Panax ginseng, P. notoginseng, P. japonicus and P. quinque-
folius) have long been used in traditional Oriental medicine.
Among those Panax species, Panax ginseng C.A. Meyer is one
of the most widely used medicinal plants in Far Eastern coun-
tries including China, Korea and Japan. It has recently been
reported that chronic intake of Panax ginseng C.A. Meyer has
been associated with decreased incidence of cancers such as
lung, gastric, liver and colorectal tumors (2, 3). Certain frac-
tions or individual ingredients of ginseng have been shown
to exert anticarcinogenic and antimutagenic activities (4-6).
The present review deals with the chemopreventive activity
of heat-processed Panax ginseng, particularly its anti-tumor
promoting potential. In an attempt to elucidate the molecular
mechanisms underlying the possible anti-tumor promoting
activity of the heat-processed Panx ginseng C.A. Meyer culti-
vated in Korea and its constituents, we have assessed their
effects on phorbol ester-induced activation and expression of
ornithine decarboxylase (ODC), a biochemical marker for
tumor promotion, and on expression of cyclooxygenase-2
(COX-2), an important enzyme that plays a key role in in-
flammation and is implicated for pathophysiology of car-
cinogenesis.
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Molecular Mechanisms Underlying Anti-Tumor Promoting Activities of
Heat-Processed Panax ginseng C.A. Meyer
Recently, there have been considerable efforts to search for naturally occurring
substances that can inhibit, reverse, or retard the multi-stage carcinogenesis. A
wide array of phenolic substances derived from edible and medicinal plants have
been reported to possess anticarcinogenic and antimutagenic activities and in
many cases, the chemopreventive activities of phytochemicals are associated
with their anti-inflammatory and/or antioxidative properties. Panax ginseng C.A.
Meyer cultivated in Korea has been widely used in traditional herbal medicine
for the treatment of various diseases. Certain fractions or purified ingredients of
ginseng have been shown to exert anticarcinogenic and antimutagenic activi-
ties. Our previous studies have revealed that the methanol extract of heat-pro-
cessed Panax ginseng C.A. Meyer attenuates the lipid peroxidation in rat brain
homogenates and is also capable of scavenging superoxide generated by xan-
thine-xanthine oxidase or by 12-O-tetradecanoylphorbol-13-acetate (TPA) in dif-
ferentiated human promyelocytic leukemia (HL-60) cells. Topical application of
the same extract onto shaven backs of female ICR mice also suppressed TPA-
induced skin tumor promotion. Likewise, topical application of ginsenoside Rg3,
one of the constituents of heat-treated ginseng, significantly inhibited TPA-induced
mouse epidermal ornithine decarboxylase activity and skin tumor promotion.
Expression of cyclooxygenase-2 (COX-2) in TPA-stimulated mouse skin was
markedly suppressed by Rg3 pretreatment. In addition, Rg3 inhibited TPA-stim-
ulated activation of NF- B and extracellular-regulated protein kinase (ERK), one
of the mitogen-activated protein (MAP) kinase in mouse skin and also in cultured
human breast epithelial cells (MCF-10A).
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AgentsANTIOXIDANT PROPERTIES OF 
HEAT-PROCESSED PANAX GINSENG
The antioxidative and free radical scavenging effects of
ginseng and some of its selected ingredients have been exten-
sively investigated and well documented (7). The methanol
extract of the heat-processed Panax ginseng significantly
inhibited the lipid peroxidation induced by ferric ion or fer-
ric ion plus ascorbic acid in rat brain homogenates (8). The
same extract also suppressed the superoxide generation con-
centration-dependently by xanthine-xanthine oxidase in vitro
and also in differentiated  human promyelocytic leukemia
(HL-60) cells stimulated with 12-O-tetradecanoylphorbol-
13-acetate (TPA) (8).
ANTI-TUMOR PROMOTING ACTIVITIES OF THE
HEAT-TREATED GINSENG AND ITS MAJOR
INGREDIENT Rg3
Reactive oxygen intermediates have been considered to
play a role in multi-stage carcinogenesis. There has been
accumulating evidence for the involvement of reactive oxy-
gen species in promoting as well as in initiating experimen-
tal carcinogenesis. Since the methanol extract of heat-pro-
cessed ginseng has an antioxidant activity, it may possess
the anti-tumor promotional potential. In support of this
possibility, topical application of the ginseng extract prior
to each topical dose of the tumor promoter TPA markedly
lowered the papilloma formation in mouse skin (8). ODC is
a rate-limiting enzyme in the biosynthesis of polyamines
that play pivotal roles in cell proliferation. Elevation of ODC
activity is closely associated with tumor promotion (9). Top-
ical application of the heat-processed ginseng extract 30
min before TPA caused substantial reduction in epidermal
ODC activity and also suppressed the expression of ODC
mRNA (8). TPA-induced production of tumor necrosis fac-
tor-alpha (TNF- ) was similarly inhibited by heat-processed
ginseng. One of the major ginsenosides present in heat-pro-
cessed ginseng is Rg3. Topical application of Rg3 onto dor-
sal skins of mice prior to TPA also resulted in inhibition of
ODC activity (unpublished).
Considerable effort is being directed towards developing
agents that can inhibit the activity of cyclooxygenase (COX).
COX is a key enzyme in prostaglandin synthesis. There are
two forms of COX enzymes, COX-1 and COX-2. While
COX-1, which is a constitutive form present in most tissues,
is involved in the physiological production of prostaglandins
for maintaining normal homeostasis, COX-2 is barely detect-
ed in normal tissues, but is readily expressed in response to
inflammatory cytokines, bacterial lipopolysaccharide, mito-
gens and reactive oxygen intermediates (10). Substantial
evidence has been accumulated to suggest that improper
elevation of COX-2 is implicated in tumorigenesis. Thus, it
was recognized that COX-2 was upregulated in transformed
cells as well as in various forms of cancer, whereas levels of
COX-1 remained unchanged (11). Overexpression of COX-
2 inhibited apoptosis and increased the invasiveness of cells.
Experimentally-induced null mutation of COX-2 reduced
the number and size of colon tumors in a murine model of
familial adenomatous polyposis (12).
To test whether Rg3 could inhibit TPA-induced COX-2
expression, we have applied Rg3 30 min prior to TPA treat-
ment and sacrificed mice after 5 hr later. Rg3 treatment caused
marked suppression of TPA-induced COX-2 expression in
mouse skin. TPA-induced expression of inducible nitric oxide
synthase (iNOS), another important enzyme responsible for
mediating inflammation, was also inhibited by Rg3 pre-
treatment (unpublished). Besides Rg3, other structurally
related ginsenosides including Rb1, Rc, Re and Rg1 (Fig. 1)
were also tested for their effects on TPA-induced COX-2
expression in mouse skin, but their inhibitory activities
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Fig. 2. Effects of selected ginsenosides on TPA-induced COX-2
expression in human breast epitelial cells (MCF-10A). MCF-10A
cells were treated with 10 nM of TPA in the absence or pres-
ence of indicated concentrations of a given ginsenoside. The
levels of COX-2 protein were determined by Western blot analy-
sis 4 hr later.
Rb1
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Re
Rg1
Rg3
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Fig. 1. Structures of various ginsenosides present in heat-pro-
cessed ginseng.were found to be relatively weaker than that of Rg3 (data
not shown). Likewise, Rg3 strongly inhibited TPA-induced
COX-2 expression in human breast epithelial cells (MCF-
10A) in culture (Fig. 2).
EFFECTS OF GINSENOSIDES ON NF- B 
ACTIVATION
NF- B is a ubiquitous eukaryotic transcription factor that
exists as a dimer composed of Rel family of proteins (13).
Several lines of evidence support that NF- B is implicated
in cellular proliferation, inflammation, and malignant trans-
formation. NF- B activation is an essential early event, which
occurs prior to malignant transformation, and contributes
to cell transformation by inhibiting cell death signal acti-
vated by oncogenic Ras (14). Constitutive activation of NF-
B has been associated with proliferation of certain cancer
cells and their resistance to apoptotic death (15, 16). Thus,
the role of NF- B in oncogenesis is evident. In an attempt
to elucidate the moleular mechanisms underlying suppres-
sion of TPA-induced expression of COX-2 by Rg3 in MCF-
10A cells, its effect on NF- B activation was compared with
those of the other ginsenosides. As illustrated in Fig. 3, TPA
treatment caused increased DNA binding of NF- B, and
all of the ginsenosides tested exerted inhibitory effects to the
different extent. In another experiment, topically applied
Rg3 suppressed TPA-induced activation of NF- B in mouse
skin (unpublished).
MODULATION OF MITOGEN-ACTIVATED 
PROTEIN (MAP) KINASES BY GINSENOSIDES
The molecular signaling mechanisms that lead to the in-
duction of COX-2 as well as activation of NF- B in response
to various external stimuli have not been fully clarified (17).
One of the most extensively investigated intracellular sig-
naling cascades involved in pro-inflammatory responses is
the mitogen-activated protein (MAP) kinase pathway. Three
distinct groups of well characterized major MAP kinases
subfamily members include extracellular-regulated protein
kinase (ERK), c-Jun NH2-protein kinase (JNK)/stress-acti-
vated protein kinase (SAPK) and p38 MAPK that are ser-
ine/threonine protein kinases. The activated form of each of
the above MAP kinases then phosphorylates and activates
other kinases or transcription factors, thereby altering the
expression of the target genes.
The induction of COX-2 and resulting production of
PGE2 were abolished by the specific inhibitors of the corre-
sponding MAP kinases, suggesting that the MAP kinase
cascade is responsible, at least in part, for up-regulation of
COX-2. Treatment of MCF-10A cells with 10 nM TPA led
to rapid activation of ERK, whereas p38 MAP kinase was
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NF- B
Fig. 3. Effects of ginsenosides on NF- B activation in MCF-
10A cells stimulated with TPA. Nuclear extracts were obtained
2 hr after 10 nM TPA treatment in the absence or presence of
indicated concentrations of each ginsenoside, and NF- B
DNA binding activity was measured by gel shift assay.
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Fig. 4. Effects of TPA on activation of ERK and p38 MAP kinas-
es in MCF-10A cells. MCF-10A cells exposed to 10 nM TPA
were harvested at the indicated time intervals and subjected to
immunoblot analysis using an phospho-specific antibody
against each kinase.
P-ERK
P-p38
DMSO
Untreated
30 15 5 45 60 (min)
TPA
Fig. 5. Effects of various ginsenosides on TPA-induced ERK
activation in MCF-10A cells. The levels of phosphorylated ERK
were meaured as described in the legend to Fig. 4.
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+TPAnot much induced (Fig. 4). We then evaluated the possible
inhibitory effects of various ginsenosides on ERK activation
in TPA-stimulated MCF-10A cells. As shown in Fig. 5, Rg3
exhibited the most potent inhibitory activity.
CONCLUSIONS
The heat-processed Panax ginseng has potent antioxidative
and anti-tumor promoting activities. Rg3, one of the major
ginsenosides contained in heat-processed ginseng, also
inhibits tumor promotion and ODC activity induced by
TPA in mouse skin. Inflammatory tissue damage has been
closely associated with tumor promotion. Rg3 inhibits the
TPA-induced expression of the proinflammatory enzyme,
COX-2 in both mouse skin and the human breast epithelial
cell line (MCF-10A). Rg3 also inhibits TPA-induced acti-
vation of NF- B and ERK, an upstream kinase known to
play a role in regulating NF- B activation.  These findings,
taken together, suggest that the previously observed anti-
tumor promoting effects of heat-processed ginseng and its
ingredient Rg3 are mediated through suppression of intra-
cellular signaling cascades responsible for activation of
NF- B and and subsequent induction of COX-2.
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